Who owns Cardiol Therapeutics Inc- foreign stock?
- Ticker: CRDL
- CUSIP Number: 14161y200
Tip: Access positions for across all investors
Analyze quarterly positions in Cardiol Therapeutics Inc- foreign with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Cardiol Therapeutics Inc- foreign stock
Who bought or sold Cardiol Therapeutics Inc- foreign stock this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Tejara Capital | 5.1M | $6.9M | 0% | Mar 2026 |
|
| Ikarian Capital | 2.7M | $3.7M | 100% | Mar 2026 |
|
| Citadel Advisors | 897k | $1.2M | 910% | Mar 2026 |
|
| Boothbay Fund Management | 795k | $1.1M | 100% | Mar 2026 |
|
| Two Sigma Investments | 534k | $721k | 31% | Mar 2026 |
|
| Integrity Alliance | 465k | $630k | 7% | Mar 2026 |
|
| Goldman Sachs Group | 332k | $449k | 1% | Mar 2026 |
|
| Morgan Stanley | 250k | $338k | 100% | Mar 2026 |
|
| MMCAP International Inc. SPC | 209k | $199k | -29% | Dec 2025 |
|
| Susquehanna International | 204k | $194k | 118% | Dec 2025 |
|
| Jane Street | 173k | $235k | 109% | Mar 2026 |
|
| Marshall Wace | 152k | $144k | -72% | Dec 2025 |
|
| Summit Financial | 104k | $141k | 0% | Mar 2026 |
|
| Knoll Capital Management | 100k | $135k | 0% | Mar 2026 |
|
| Goodman & Company, Investment Counsel | 100k | $95k | 100% | Dec 2025 |
|
| We Are One Seven | 100k | $95k | 0% | Dec 2025 |
|
| Pvg Asset Management | 97k | $93k | -32% | Dec 2025 |
|
| Geode Capital Management | 52k | $71k | 0% | Mar 2026 |
|
| Marble Harbor Investment Counsel | 40k | $54k | 0% | Mar 2026 |
|
| Security National Bank Of Sioux City Iowa | 33k | $45k | 0% | Mar 2026 |
|
| Simplex Trading | 32k | $31k | 96% | Dec 2025 |
|
| Kovack Advisors | 30k | $42k | 100% | Mar 2026 |
|
| Boyer Financial Services | 23k | $31k | -30% | Mar 2026 |
|
| Mercer Global Advisors | 23k | $31k | 0% | Mar 2026 |
|
| Royal Bank of Canada | 22k | $29k | 74% | Mar 2026 |
|
| Jones Financial Companies, L.L | 20k | $19k | -6% | Dec 2025 |
|
| Baader Bank | 16k | $10k | 100% | Mar 2026 |
|
| Scientech Research | 15k | $21k | 100% | Mar 2026 |
|
| Sontag Advisory | 15k | $21k | 0% | Mar 2026 |
|
| MONECO Advisors | 15k | $20k | 0% | Mar 2026 |
|
| Boomfish Wealth Group | 14k | $20k | 100% | Mar 2026 |
|
| Eaton Financial Holdings Company | 14k | $19k | 100% | Mar 2026 |
|
| Commonwealth Equity Services | 11k | $15k | 3% | Mar 2026 |
|
| Impact Partnership Wealth | 11k | $15k | -65% | Mar 2026 |
|
| Independent Advisor Alliance | 10k | $14k | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 10k | $14k | 100% | Mar 2026 |
|
| UBS Group | 8.6k | $12k | -48% | Mar 2026 |
|
| TD Waterhouse Canada | 6.9k | $9.5k | -4% | Mar 2026 |
|
| Piscataqua Savings Bank | 5.0k | $10k | 0% | Mar 2026 |
|
| Valley National Advisers | 5.0k | $6.0k | 0% | Mar 2026 |
|
| National Bank Of Canada /fi/ | 1.7k | $1.6k | 9% | Dec 2025 |
|
| Advisor Group Holdings | 687.00 | $658.970400 | -60% | Dec 2025 |
|
| SBI Securities | 475.00 | $641.012500 | 0% | Mar 2026 |
|
Who sold out of Cardiol Therapeutics Inc- foreign?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| AdvisorShares Investments | Dec 2025 | 598k | $570k |
| Virtu Financial | Sep 2025 | 144k | $154k |
| Two Sigma Advisers | Dec 2025 | 19k | $18k |
| Wealth Enhancement Advisory Services | Dec 2025 | 17k | $17k |
| Goss Wealth Management | Dec 2025 | 5.0k | $4.8k |
| Disciplined Equity Management | Dec 2025 | 500.00 | $605.000000 |